{
    "xml": "<topic id=\"PHP3575\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/co-trimoxazole\" basename=\"co-trimoxazole\" title=\"CO-TRIMOXAZOLE\">\n<title>CO-TRIMOXAZOLE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_208\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/sulfonamides/sulfamethoxazole\">Sulfamethoxazole</xref>, <xref format=\"dita\" href=\"#bnf_int_217\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/trimethoprim\">Trimethoprim</xref>\n</p>\n<data name=\"vtmid\">18037511000001105</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_347407165\" title=\"Diaminopyrimidines\">Diaminopyrimidines</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP40374\" outputclass=\"drugAction\" rev=\"1.11\" parent=\"/drugs/co-trimoxazole\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Sulfamethoxazole and trimethoprim are used in combination (as <b>co-trimoxazole</b>) because of their synergistic activity (the importance of the sulfonamides has decreased as a result of increasing bacterial resistance and their replacement by antibacterials which are generally more active and less toxic).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40331\" outputclass=\"indicationsAndDose\" rev=\"1.36\" parent=\"/drugs/co-trimoxazole\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of susceptible infections</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 6 weeks&#8211;5 months</p>\n<p>120&#8239;mg twice daily, alternatively 24&#8239;mg/kg twice daily.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 6 months&#8211;5 years</p>\n<p>240&#8239;mg twice daily, alternatively 24&#8239;mg/kg twice daily.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;11 years</p>\n<p>480&#8239;mg twice daily, alternatively 24&#8239;mg/kg twice daily.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>960&#8239;mg twice daily.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>960&#8239;mg twice daily.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>960&#8239;mg every 12&#8239;hours, increased to 1.44&#8239;g every 12&#8239;hours, increased dose used in severe infection.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of <ph outputclass=\"organism\">\n<i>Pneumocystis jirovecii</i>\n</ph> (<ph outputclass=\"organism\">\n<i>Pneumocystis carinii</i>\n</ph> ) infections (undertaken where facilities for appropriate monitoring available&#8212;consult microbiologist and product literature)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>120&#8239;mg/kg daily in 2&#8211;4 divided doses for 14&#8211;21 days, oral route preferred for children.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>120&#8239;mg/kg daily in 2&#8211;4 divided doses for 14&#8211;21 days, oral route preferred for children.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of <ph outputclass=\"organism\">\n<i>Pneumocystis jirovecii</i>\n</ph> (<ph outputclass=\"organism\">\n<i>Pneumocystis carinii</i>\n</ph> ) infections</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>450&#8239;mg/m<sup>2</sup> twice daily (max. per dose 960&#8239;mg twice daily) for 3 days of the week (either consecutively or on alternate days), dose regimens may vary, consult local guidelines.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>960&#8239;mg once daily, reduced if not tolerated to 480&#8239;mg once daily, alternatively 960&#8239;mg once daily on alternate days, alternate day dose to be given 3 times weekly, alternatively 960&#8239;mg twice a day on alternate days, alternate day dose to be given 3 times weekly.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>480&#8239;mg of co-trimoxazole consists of sulfamethoxazole 400&#8239;mg and trimethoprim 80&#8239;mg. </p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40234\" outputclass=\"unlicensedUse\" rev=\"1.21\" parent=\"/drugs/co-trimoxazole\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Not licensed for use in children under 6 weeks.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Not licensed for <ph outputclass=\"organism\">\n<i>Burkholderia cepacia</i>\n</ph> infections in cystic fibrosis.</p>\n<p>Not licensed for <ph outputclass=\"organism\">\n<i>Stenotrophomonas maltophilia</i>\n</ph> infections.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40380\" outputclass=\"importantSafetyInformation\" rev=\"1.8\" parent=\"/drugs/co-trimoxazole\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Restrictions on the use of co-trimoxazole</p>\n<p>Co-trimoxazole is the drug of choice in the prophylaxis and treatment of <ph outputclass=\"organism\">\n<i>Pneumocystis jirovecii</i>\n</ph> (<ph outputclass=\"organism\">\n<i>Pneumocystis carinii</i>\n</ph>) pneumonia; it is also indicated for nocardiasis, <ph outputclass=\"organism\">\n<i>Stenotrophomonas maltophilia</i>\n</ph> infection [unlicensed indication], and toxoplasmosis. It should only be considered for use in acute exacerbations of chronic bronchitis and infections of the urinary tract when there is bacteriological evidence of sensitivity to co-trimoxazole and good reason to prefer this combination to a single antibacterial; similarly it should only be used in acute otitis media in children when there is good reason to prefer it. Co-trimoxazole is also used for the treatment of infections caused by <ph outputclass=\"organism\">\n<i>Burkholderia cepacia</i>\n</ph> in cystic fibrosis [unlicensed indication].</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40388\" outputclass=\"contraindications\" rev=\"1.23\" parent=\"/drugs/co-trimoxazole\">\n<title>Contra-indications</title>\n<body>\r\n<section outputclass=\"contraindications\">\r\n<p>\r\n<ph outputclass=\"contraindication\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>\r\n</p>\r\n </section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP40417\" outputclass=\"cautions\" rev=\"1.26\" parent=\"/drugs/co-trimoxazole\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Asthma</ph>; <ph outputclass=\"caution\">avoid in blood disorders (unless under specialist supervision)</ph>; <ph outputclass=\"caution\">avoid in infants under 6 weeks (except for treatment or prophylaxis of pneumocystis pneumonia) because of the risk of kernicterus</ph>; <ph outputclass=\"caution\">elderly (increased risk of serious side-effects)</ph> (in adults); <ph outputclass=\"caution\">G6PD deficiency (risk of haemolytic anaemia)</ph>; <ph outputclass=\"caution\">maintain adequate fluid intake</ph>; <ph outputclass=\"caution\">predisposition to folate deficiency</ph>; <ph outputclass=\"caution\">predisposition to hyperkalaemia</ph> (in adults)</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40299\" outputclass=\"interactions\" rev=\"1.9\" parent=\"/drugs/co-trimoxazole\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (trimethoprim, sulfamethoxazole).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40267\" outputclass=\"sideEffects\" rev=\"1.27\" parent=\"/drugs/co-trimoxazole\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Diarrhoea</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hyperkalaemia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">rash</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Agranulocytosis</ph>; <ph outputclass=\"sideEffect\">bone marrow depression</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anorexia</ph>; <ph outputclass=\"sideEffect\">antibiotic-associated colitis</ph>; <ph outputclass=\"sideEffect\">arthralgia</ph>; <ph outputclass=\"sideEffect\">aseptic meningitis</ph>; <ph outputclass=\"sideEffect\">ataxia</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">convulsions</ph>; <ph outputclass=\"sideEffect\">cough</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">eosinophilia</ph>; <ph outputclass=\"sideEffect\">glossitis</ph>; <ph outputclass=\"sideEffect\">hallucinations</ph>; <ph outputclass=\"sideEffect\">hepatic necrosis</ph>; <ph outputclass=\"sideEffect\">hypoglycaemia</ph>; <ph outputclass=\"sideEffect\">hyponatraemia</ph>; <ph outputclass=\"sideEffect\">interstitial nephritis</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">liver damage</ph>; <ph outputclass=\"sideEffect\">megaloblastic anaemia</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">myocarditis</ph>; <ph outputclass=\"sideEffect\">pancreatitis</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">pulmonary infiltrates</ph>; <ph outputclass=\"sideEffect\">renal disorders</ph>; <ph outputclass=\"sideEffect\">shortness of breath</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">stomatitis</ph>; <ph outputclass=\"sideEffect\">systemic lupus erythematosus</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>; <ph outputclass=\"sideEffect\">tinnitus</ph>; <ph outputclass=\"sideEffect\">toxic epidermal necrolysis</ph>; <ph outputclass=\"sideEffect\">uveitis</ph>; <ph outputclass=\"sideEffect\">vasculitis</ph>; <ph outputclass=\"sideEffect\">vertigo</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Rhabdomyolysis reported in HIV-infected patients</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Blood disorders or rash</p>\n<p>Co-trimoxazole is associated with rare but serious side effects. Discontinue immediately if blood disorders (including leucopenia, thrombocytopenia, megaloblastic anaemia, eosinophilia) or rash (including Stevens-Johnson syndrome, toxic epidermal necrolysis, photosensitivity) develop.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40297\" outputclass=\"pregnancy\" parent=\"/drugs/co-trimoxazole\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Teratogenic risk in first trimester (trimethoprim a folate antagonist).</p>\n<p>Neonatal haemolysis and methaemoglobinaemia in third trimester; fear of increased risk of kernicterus in neonates appears to be unfounded.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40447\" outputclass=\"breastFeeding\" parent=\"/drugs/co-trimoxazole\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Small risk of kernicterus in jaundiced infants and of haemolysis in G6PD-deficient infants (due to sulfamethoxazole).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40352\" outputclass=\"hepaticImpairment\" parent=\"/drugs/co-trimoxazole\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid in severe liver disease.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40287\" outputclass=\"renalImpairment\" parent=\"/drugs/co-trimoxazole\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Use half normal dose if eGFR 15&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Use half normal dose if estimated glomerular filtration rate 15&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Avoid if eGFR less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup> and if plasma-sulfamethoxazole concentration cannot be monitored.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Avoid if estimated glomerular filtration rate less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup> and if plasma-sulfamethoxazole concentration cannot be monitored.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40228\" outputclass=\"monitoringRequirements\" parent=\"/drugs/co-trimoxazole\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"therapeuticDrugMonitoring\">\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Plasma concentration monitoring may be required with high doses; seek expert advice.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor blood counts on prolonged treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40465\" outputclass=\"directionsForAdministration\" rev=\"1.12\" parent=\"/drugs/co-trimoxazole\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For intermittent <i>intravenous infusion</i>, may be further diluted in glucose 5% and 10% or sodium chloride 0.9%. Dilute contents of 1 ampoule (5&#8239;mL) to 125&#8239;mL, 2 ampoules (10&#8239;mL) to 250&#8239;mL or 3 ampoules (15&#8239;mL) to 500&#8239;mL; suggested duration of infusion 60&#8211;90 minutes (but may be adjusted according to fluid requirements); if fluid restriction necessary, 1 ampoule (5&#8239;mL) may be diluted with 75&#8239;mL glucose 5% and the required dose infused over max. 60 minutes; check container for haze or precipitant during administration. In severe fluid restriction may be given undiluted via a central venous line.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i> (<i>Septrin</i>\n<tm tmtype=\"reg\"/>\n<i>for infusion</i>), give intermittently <i>in</i> Glucose 5% or 10% <i>or</i> Sodium chloride 0.9%. Dilute contents of 1 ampoule (5&#8239;mL) to 125&#8239;mL, 2 ampoules (10&#8239;mL) to 250&#8239;mL or 3 ampoules (15&#8239;mL) to 500&#8239;mL; suggested duration of infusion 60&#8211;90 minutes (but may be adjusted according to fluid requirements); if fluid restriction necessary, 1 ampoule (5&#8239;mL) may be diluted with 75&#8239;mL glucose 5% and infused over max. 60 minutes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58362\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.15\" parent=\"/drugs/co-trimoxazole\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Co-trimoxazole is a mixture of trimethoprim and sulfamethoxazole (sulphamethoxazole) in the proportions of 1 part to 5 parts.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in adults</p>\n<p>Flavours of oral liquid formulations may include vanilla.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>Flavours of oral liquid formulations may include banana, or vanilla.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3575-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/co-trimoxazole\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75167\" title=\"Tablet\" namespace=\"/drugs/co-trimoxazole/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75175\" title=\"Oral suspension\" namespace=\"/drugs/co-trimoxazole/oral-suspension\">Oral suspension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75182\" title=\"Solution for infusion\" namespace=\"/drugs/co-trimoxazole/solution-for-infusion\">Solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP98618\" namespace=\"/guidance/prescribing-for-the-elderly\" title=\"Prescribing for the elderly\" count=\"1\" rel=\"backlink\">Prescribing for the elderly</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78452\" namespace=\"/treatment-summaries/pneumocystis-pneumonia\" title=\"Pneumocystis pneumonia\" count=\"6\" rel=\"backlink\">Pneumocystis pneumonia</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78553\" namespace=\"/treatment-summaries/central-nervous-system-infections-bacterial\" title=\"Central nervous system infections, bacterial\" count=\"1\" rel=\"backlink\">Central nervous system infections, bacterial</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_208\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/sulfonamides/sulfamethoxazole\" title=\"Sulfamethoxazole\" count=\"1\" rel=\"link\">Sulfamethoxazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_217\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/trimethoprim\" title=\"Trimethoprim\" count=\"1\" rel=\"link\">Trimethoprim</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75167\" namespace=\"/drugs/co-trimoxazole/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75175\" namespace=\"/drugs/co-trimoxazole/oral-suspension\" title=\"Oral suspension\" count=\"1\" rel=\"link\">Oral suspension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75182\" namespace=\"/drugs/co-trimoxazole/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP3575",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/co-trimoxazole",
    "basename": "co-trimoxazole",
    "title": "CO-TRIMOXAZOLE",
    "interactants": [
        {
            "id": "bnf_int_208",
            "label": "Sulfamethoxazole"
        },
        {
            "id": "bnf_int_217",
            "label": "Trimethoprim"
        }
    ],
    "vtmid": "18037511000001105",
    "drugClassification": [
        "Diaminopyrimidines"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Sulfamethoxazole and trimethoprim are used in combination (as co-trimoxazole) because of their synergistic activity (the importance of the sulfonamides has decreased as a result of increasing bacterial resistance and their replacement by antibacterials which are generally more active and less toxic).",
                "html": "<p>Sulfamethoxazole and trimethoprim are used in combination (as <b>co-trimoxazole</b>) because of their synergistic activity (the importance of the sulfonamides has decreased as a result of increasing bacterial resistance and their replacement by antibacterials which are generally more active and less toxic).</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of susceptible infections",
                        "html": "Treatment of susceptible infections"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "120 mg twice daily, alternatively 24 mg/kg twice daily.",
                        "html": "<p>120&#8239;mg twice daily, alternatively 24&#8239;mg/kg twice daily.</p>",
                        "ageGroup": "6 weeks&#8211;5 months"
                    },
                    {
                        "textContent": "240 mg twice daily, alternatively 24 mg/kg twice daily.",
                        "html": "<p>240&#8239;mg twice daily, alternatively 24&#8239;mg/kg twice daily.</p>",
                        "ageGroup": "6 months&#8211;5 years"
                    },
                    {
                        "textContent": "480 mg twice daily, alternatively 24 mg/kg twice daily.",
                        "html": "<p>480&#8239;mg twice daily, alternatively 24&#8239;mg/kg twice daily.</p>",
                        "ageGroup": "6&#8211;11 years"
                    },
                    {
                        "textContent": "960 mg twice daily.",
                        "html": "<p>960&#8239;mg twice daily.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "960 mg twice daily.",
                        "html": "<p>960&#8239;mg twice daily.</p>"
                    },
                    {
                        "textContent": "960 mg every 12 hours, increased to 1.44 g every 12 hours, increased dose used in severe infection.",
                        "html": "<p>960&#8239;mg every 12&#8239;hours, increased to 1.44&#8239;g every 12&#8239;hours, increased dose used in severe infection.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of Pneumocystis jirovecii ( Pneumocystis carinii ) infections (undertaken where facilities for appropriate monitoring available&#8212;consult microbiologist and product literature)",
                        "html": "Treatment of <ph outputclass=\"organism\"> <i>Pneumocystis jirovecii</i> </ph> (<ph outputclass=\"organism\"> <i>Pneumocystis carinii</i> </ph> ) infections (undertaken where facilities for appropriate monitoring available&#8212;consult microbiologist and product literature)",
                        "organism": "Pneumocystis carinii"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth or intravenous infusion"
                    ],
                    "textContent": "By mouth or by intravenous infusion",
                    "html": "By mouth or by intravenous infusion",
                    "organism": "Pneumocystis carinii"
                },
                "child": [
                    {
                        "textContent": "120 mg/kg daily in 2&#8211;4 divided doses for 14&#8211;21 days, oral route preferred for children.",
                        "html": "<p>120&#8239;mg/kg daily in 2&#8211;4 divided doses for 14&#8211;21 days, oral route preferred for children.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "120 mg/kg daily in 2&#8211;4 divided doses for 14&#8211;21 days, oral route preferred for children.",
                        "html": "<p>120&#8239;mg/kg daily in 2&#8211;4 divided doses for 14&#8211;21 days, oral route preferred for children.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of Pneumocystis jirovecii ( Pneumocystis carinii ) infections",
                        "html": "Prophylaxis of <ph outputclass=\"organism\"> <i>Pneumocystis jirovecii</i> </ph> (<ph outputclass=\"organism\"> <i>Pneumocystis carinii</i> </ph> ) infections",
                        "organism": "Pneumocystis carinii"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth",
                    "organism": "Pneumocystis carinii"
                },
                "child": [
                    {
                        "textContent": "450 mg/m2 twice daily (max. per dose 960 mg twice daily) for 3 days of the week (either consecutively or on alternate days), dose regimens may vary, consult local guidelines.",
                        "html": "<p>450&#8239;mg/m<sup>2</sup> twice daily (max. per dose 960&#8239;mg twice daily) for 3 days of the week (either consecutively or on alternate days), dose regimens may vary, consult local guidelines.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "960 mg once daily, reduced if not tolerated to 480 mg once daily, alternatively 960 mg once daily on alternate days, alternate day dose to be given 3 times weekly, alternatively 960 mg twice a day on alternate days, alternate day dose to be given 3 times weekly.",
                        "html": "<p>960&#8239;mg once daily, reduced if not tolerated to 480&#8239;mg once daily, alternatively 960&#8239;mg once daily on alternate days, alternate day dose to be given 3 times weekly, alternatively 960&#8239;mg twice a day on alternate days, alternate day dose to be given 3 times weekly.</p>"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "480 mg of co-trimoxazole consists of sulfamethoxazole 400 mg and trimethoprim 80 mg.",
                "html": "<p>480&#8239;mg of co-trimoxazole consists of sulfamethoxazole 400&#8239;mg and trimethoprim 80&#8239;mg. </p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Not licensed for use in children under 6 weeks.",
                "html": "<p>Not licensed for use in children under 6 weeks.</p>"
            },
            {
                "type": "unlicensedUse",
                "textContent": "Not licensed for Burkholderia cepacia infections in cystic fibrosis.\n\nNot licensed for Stenotrophomonas maltophilia infections.",
                "html": "<p>Not licensed for <ph outputclass=\"organism\">\n<i>Burkholderia cepacia</i>\n</ph> infections in cystic fibrosis.</p><p>Not licensed for <ph outputclass=\"organism\">\n<i>Stenotrophomonas maltophilia</i>\n</ph> infections.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "title": "Restrictions on the use of co-trimoxazole",
                "textContent": "Co-trimoxazole is the drug of choice in the prophylaxis and treatment of Pneumocystis jirovecii ( Pneumocystis carinii ) pneumonia; it is also indicated for nocardiasis, Stenotrophomonas maltophilia infection [unlicensed indication], and toxoplasmosis. It should only be considered for use in acute exacerbations of chronic bronchitis and infections of the urinary tract when there is bacteriological evidence of sensitivity to co-trimoxazole and good reason to prefer this combination to a single antibacterial; similarly it should only be used in acute otitis media in children when there is good reason to prefer it. Co-trimoxazole is also used for the treatment of infections caused by Burkholderia cepacia in cystic fibrosis [unlicensed indication].",
                "html": "<p>Co-trimoxazole is the drug of choice in the prophylaxis and treatment of <ph outputclass=\"organism\">\n<i>Pneumocystis jirovecii</i>\n</ph> (<ph outputclass=\"organism\">\n<i>Pneumocystis carinii</i>\n</ph>) pneumonia; it is also indicated for nocardiasis, <ph outputclass=\"organism\">\n<i>Stenotrophomonas maltophilia</i>\n</ph> infection [unlicensed indication], and toxoplasmosis. It should only be considered for use in acute exacerbations of chronic bronchitis and infections of the urinary tract when there is bacteriological evidence of sensitivity to co-trimoxazole and good reason to prefer this combination to a single antibacterial; similarly it should only be used in acute otitis media in children when there is good reason to prefer it. Co-trimoxazole is also used for the treatment of infections caused by <ph outputclass=\"organism\">\n<i>Burkholderia cepacia</i>\n</ph> in cystic fibrosis [unlicensed indication].</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Asthma",
                "html": "Asthma"
            },
            {
                "type": "cautions",
                "textContent": "avoid in blood disorders (unless under specialist supervision)",
                "html": "avoid in blood disorders (unless under specialist supervision)"
            },
            {
                "type": "cautions",
                "textContent": "avoid in infants under 6 weeks (except for treatment or prophylaxis of pneumocystis pneumonia) because of the risk of kernicterus",
                "html": "avoid in infants under 6 weeks (except for treatment or prophylaxis of pneumocystis pneumonia) because of the risk of kernicterus"
            },
            {
                "type": "cautions",
                "textContent": "elderly (increased risk of serious side-effects) in adults",
                "html": "elderly (increased risk of serious side-effects) in adults",
                "specificity": {
                    "patientType": "adults"
                }
            },
            {
                "type": "cautions",
                "textContent": "G6PD deficiency (risk of haemolytic anaemia)",
                "html": "G6PD deficiency (risk of haemolytic anaemia)"
            },
            {
                "type": "cautions",
                "textContent": "maintain adequate fluid intake",
                "html": "maintain adequate fluid intake"
            },
            {
                "type": "cautions",
                "textContent": "predisposition to folate deficiency",
                "html": "predisposition to folate deficiency"
            },
            {
                "type": "cautions",
                "textContent": "predisposition to hyperkalaemia in adults",
                "html": "predisposition to hyperkalaemia in adults",
                "specificity": {
                    "patientType": "adults"
                }
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (trimethoprim, sulfamethoxazole).",
                "html": "<p>Appendix 1 (trimethoprim, sulfamethoxazole).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Diarrhoea",
                        "html": "Diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hyperkalaemia",
                        "html": "hyperkalaemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Vomiting",
                        "html": "Vomiting",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Agranulocytosis",
                        "html": "Agranulocytosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "bone marrow depression",
                        "html": "bone marrow depression",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Anorexia",
                        "html": "Anorexia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "antibiotic-associated colitis",
                        "html": "antibiotic-associated colitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "arthralgia",
                        "html": "arthralgia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "aseptic meningitis",
                        "html": "aseptic meningitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "ataxia",
                        "html": "ataxia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "blood disorders",
                        "html": "blood disorders",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "convulsions",
                        "html": "convulsions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "cough",
                        "html": "cough",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "eosinophilia",
                        "html": "eosinophilia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "glossitis",
                        "html": "glossitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hallucinations",
                        "html": "hallucinations",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hepatic necrosis",
                        "html": "hepatic necrosis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hypoglycaemia",
                        "html": "hypoglycaemia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hyponatraemia",
                        "html": "hyponatraemia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "interstitial nephritis",
                        "html": "interstitial nephritis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "liver damage",
                        "html": "liver damage",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "megaloblastic anaemia",
                        "html": "megaloblastic anaemia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "myocarditis",
                        "html": "myocarditis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "pancreatitis",
                        "html": "pancreatitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "peripheral neuropathy",
                        "html": "peripheral neuropathy",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "pulmonary infiltrates",
                        "html": "pulmonary infiltrates",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "renal disorders",
                        "html": "renal disorders",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "shortness of breath",
                        "html": "shortness of breath",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "stomatitis",
                        "html": "stomatitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "systemic lupus erythematosus",
                        "html": "systemic lupus erythematosus",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "tinnitus",
                        "html": "tinnitus",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "toxic epidermal necrolysis",
                        "html": "toxic epidermal necrolysis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "uveitis",
                        "html": "uveitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "vasculitis",
                        "html": "vasculitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "vertigo",
                        "html": "vertigo",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Rhabdomyolysis reported in HIV-infected patients",
                        "html": "Rhabdomyolysis reported in HIV-infected patients",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Blood disorders or rash",
                "textContent": "Co-trimoxazole is associated with rare but serious side effects. Discontinue immediately if blood disorders (including leucopenia, thrombocytopenia, megaloblastic anaemia, eosinophilia) or rash (including Stevens-Johnson syndrome, toxic epidermal necrolysis, photosensitivity) develop.",
                "html": "<p>Co-trimoxazole is associated with rare but serious side effects. Discontinue immediately if blood disorders (including leucopenia, thrombocytopenia, megaloblastic anaemia, eosinophilia) or rash (including Stevens-Johnson syndrome, toxic epidermal necrolysis, photosensitivity) develop.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Teratogenic risk in first trimester (trimethoprim a folate antagonist).\n\nNeonatal haemolysis and methaemoglobinaemia in third trimester; fear of increased risk of kernicterus in neonates appears to be unfounded.",
                "html": "<p>Teratogenic risk in first trimester (trimethoprim a folate antagonist).</p><p>Neonatal haemolysis and methaemoglobinaemia in third trimester; fear of increased risk of kernicterus in neonates appears to be unfounded.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Small risk of kernicterus in jaundiced infants and of haemolysis in G6PD-deficient infants (due to sulfamethoxazole).",
                "html": "<p>Small risk of kernicterus in jaundiced infants and of haemolysis in G6PD-deficient infants (due to sulfamethoxazole).</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid in severe liver disease.",
                "html": "<p>Manufacturer advises avoid in severe liver disease.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Use half normal dose if eGFR 15&#8211;30 mL/minute/1.73 m2.",
                "html": "<p>Use half normal dose if eGFR 15&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Use half normal dose if estimated glomerular filtration rate 15&#8211;30 mL/minute/1.73 m2.",
                "html": "<p>Use half normal dose if estimated glomerular filtration rate 15&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Avoid if eGFR less than 15 mL/minute/1.73 m2 and if plasma-sulfamethoxazole concentration cannot be monitored.",
                "html": "<p>Avoid if eGFR less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup> and if plasma-sulfamethoxazole concentration cannot be monitored.</p>"
            },
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Avoid if estimated glomerular filtration rate less than 15 mL/minute/1.73 m2 and if plasma-sulfamethoxazole concentration cannot be monitored.",
                "html": "<p>Avoid if estimated glomerular filtration rate less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup> and if plasma-sulfamethoxazole concentration cannot be monitored.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "therapeuticDrugMonitoring": [
            {
                "type": "therapeuticDrugMonitoring",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Plasma concentration monitoring may be required with high doses; seek expert advice.",
                "html": "<p>Plasma concentration monitoring may be required with high doses; seek expert advice.</p>"
            }
        ],
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor blood counts on prolonged treatment.",
                "html": "<p>Monitor blood counts on prolonged treatment.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intermittent intravenous infusion, may be further diluted in glucose 5% and 10% or sodium chloride 0.9%. Dilute contents of 1 ampoule (5 mL) to 125 mL, 2 ampoules (10 mL) to 250 mL or 3 ampoules (15 mL) to 500 mL; suggested duration of infusion 60&#8211;90 minutes (but may be adjusted according to fluid requirements); if fluid restriction necessary, 1 ampoule (5 mL) may be diluted with 75 mL glucose 5% and the required dose infused over max. 60 minutes; check container for haze or precipitant during administration. In severe fluid restriction may be given undiluted via a central venous line.",
                "html": "<p>For intermittent <i>intravenous infusion</i>, may be further diluted in glucose 5% and 10% or sodium chloride 0.9%. Dilute contents of 1 ampoule (5&#8239;mL) to 125&#8239;mL, 2 ampoules (10&#8239;mL) to 250&#8239;mL or 3 ampoules (15&#8239;mL) to 500&#8239;mL; suggested duration of infusion 60&#8211;90 minutes (but may be adjusted according to fluid requirements); if fluid restriction necessary, 1 ampoule (5&#8239;mL) may be diluted with 75&#8239;mL glucose 5% and the required dose infused over max. 60 minutes; check container for haze or precipitant during administration. In severe fluid restriction may be given undiluted via a central venous line.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Septrin for infusion), give intermittently in Glucose 5% or 10% or Sodium chloride 0.9%. Dilute contents of 1 ampoule (5 mL) to 125 mL, 2 ampoules (10 mL) to 250 mL or 3 ampoules (15 mL) to 500 mL; suggested duration of infusion 60&#8211;90 minutes (but may be adjusted according to fluid requirements); if fluid restriction necessary, 1 ampoule (5 mL) may be diluted with 75 mL glucose 5% and infused over max. 60 minutes.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Septrin</i>\n<tm tmtype=\"reg\"/>\n<i>for infusion</i>), give intermittently <i>in</i> Glucose 5% or 10% <i>or</i> Sodium chloride 0.9%. Dilute contents of 1 ampoule (5&#8239;mL) to 125&#8239;mL, 2 ampoules (10&#8239;mL) to 250&#8239;mL or 3 ampoules (15&#8239;mL) to 500&#8239;mL; suggested duration of infusion 60&#8211;90 minutes (but may be adjusted according to fluid requirements); if fluid restriction necessary, 1 ampoule (5&#8239;mL) may be diluted with 75&#8239;mL glucose 5% and infused over max. 60 minutes.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Co-trimoxazole is a mixture of trimethoprim and sulfamethoxazole (sulphamethoxazole) in the proportions of 1 part to 5 parts.",
                "html": "<p>Co-trimoxazole is a mixture of trimethoprim and sulfamethoxazole (sulphamethoxazole) in the proportions of 1 part to 5 parts.</p>"
            },
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "With oral use in adults",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Flavours of oral liquid formulations may include vanilla.",
                "html": "<p>Flavours of oral liquid formulations may include vanilla.</p>"
            },
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Flavours of oral liquid formulations may include banana, or vanilla.",
                "html": "<p>Flavours of oral liquid formulations may include banana, or vanilla.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75167",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75175",
                "label": "Oral suspension",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75182",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP98618",
                "label": "Prescribing for the elderly",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78452",
                "label": "Pneumocystis pneumonia",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78553",
                "label": "Central nervous system infections, bacterial",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_208",
                "label": "Sulfamethoxazole",
                "type": "interaction"
            },
            {
                "id": "bnf_int_217",
                "label": "Trimethoprim",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75167",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75175",
                "label": "Oral suspension",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75182",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}